Israeli based Biogal-Galed Labs, has joined forced with Modern Veterinary Therapeutics, LLC (Miami, FL) to announce the official launch of a canine vaccination product, called VacciCheck. Biogal will officially launch the Canine VacciCheck in the USA at the North American Veterinary Conference (NAVC) on January 15-19th 2011 in Orlando, Florida. This conference is the major event of the year in the United States for the small animal veterinarian industry, attracting over 15,000 participants.

“We at Biogal see this as an ideal opportunity to present to our customers a product that can assist in reducing over vaccination and subsequent potential adverse reactions for dogs” said Amos Gershony, Biogal’s General Manager.

The Canine VacciCheck kit is intended to be used as a diagnostic tool to evaluate the antibody response to the core vaccination or infection by Infectious Canine Hepatitis, Canine Parvovirus and Distemper Virus.

This test is especially useful to determine if a dog requires additional vaccination, and may save the dog unnecessary vaccination. It is can also help determine the vaccination status of a dog with unknown vaccination history or help determine if puppies have received immunity from vaccination.

What is unique about Biogal’s Canine VacciCheck is that it gives the veterinarian the opportunity of being able to assess all the 3 core vaccines. This is all done in one test as a follow up to vaccination, in the vet’s clinic or the veterinary lab, with an answer received within 20 minutes.

For more information visit: www.twitter.com/biogaled